Pharma
Sonny Shergill, vice president of commercial digital health at AstraZeneca, highlights pharma's perspective on digital health investments and partnerships for sector growth.
The Act is the world's first major law for AI implementation and provides regulations for high-risk applications of the technology, including its use in healthcare.
The company will use the funds to accelerate its growth, expand the use of its models for different conditions and open an office in Cambridge.
HIMSS24
Emmanuel Bilbault, cofounder and CEO of POSOS, says the company's AI-driven international drug database's use of medication codes enables it to cross-reference EHR data and tailor prescriptions to meet a patient's specific needs.
The company will use the funds to expand its workforce, including its sales team, in order to broaden its biopharma partnerships.
Antidote will use SEQSTER's operating system to improve clinical trial time lines and enhance patient engagement for pharma and life sciences companies.
Continuous Precision Medicine can help confirm a patient's pain medication intake so providers can better manage preventable issues, says the company's CEO and cofounder Steven Walther. However, accurate data is vital to ensuring validity.
HIMSS24
Dr. Colin Banas, CMO at DrFirst, discusses the company's medication adherence product. It uses AI to send texts that educate patients about medications and provides coupons and co-pay-assistance program information, if cost is an issue.
EvolutionaryScale's biology-focused language models for drug discovery and therapeutic development will be available to AWS customers.
Also, digital twin technology is being tested to optimise mechanical ventilation.